L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-03
DOI
10.1245/s10434-019-08103-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic significance of positive peritoneal cytology in endometrial cancer and its correlations with L1-CAM biomarker
- (2019) Enrico Vizza et al. SURGICAL ONCOLOGY-OXFORD
- L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
- (2018) Felix KF Kommoss et al. BRITISH JOURNAL OF CANCER
- Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
- (2018) B. G. Wortman et al. BRITISH JOURNAL OF CANCER
- The significance of L1CAM expression in clear cell carcinoma of the endometrium
- (2017) Oluwole Fadare et al. HISTOPATHOLOGY
- The Pleiotropic Role of L1CAM in Tumor Vasculature
- (2017) Francesca Angiolini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- L1CAM is an independent predictor of poor survival in endometrial cancer — An analysis of The Cancer Genome Atlas (TCGA)
- (2016) Thanh H. Dellinger et al. GYNECOLOGIC ONCOLOGY
- Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms
- (2016) Yasuhiko Ebina et al. International Journal of Clinical Oncology
- L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
- (2016) Yvette P. Geels et al. PATHOLOGY & ONCOLOGY RESEARCH
- TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
- (2016) Cai M. Roberts et al. Scientific Reports
- Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
- (2015) Uwe Schirmer et al. Oncotarget
- miR-21-3p is a positive regulator of L1CAM in several human carcinomas
- (2014) Kai Doberstein et al. CANCER LETTERS
- L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
- (2014) T. Bosse et al. EUROPEAN JOURNAL OF CANCER
- Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
- (2014) Takashi Mitamura et al. Journal of Gynecologic Oncology
- Overexpression of L1CAM is Associated with Tumor Progression and Prognosis via ERK Signaling in Gastric Cancer
- (2013) Takeshi Ito et al. ANNALS OF SURGICAL ONCOLOGY
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study
- (2013) Julien Mazières et al. LUNG CANCER
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- L1CAM
- (2012) Helena Kiefel et al. Cell Adhesion & Migration
- Practice pattern for postoperative management of endometrial cancer in Japan: A survey of the Japanese Gynecologic Oncology Group
- (2009) Yoh Watanabe et al. GYNECOLOGIC ONCOLOGY
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- (2009) Sergio Pecorelli INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration
- (2008) Yasmin Issa et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
- (2007) Nobuyuki Susumu et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search